Company MYnd Analytics Inc Nasdaq
Equities
US62857N2027
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical
100.0
%
| 21 | 100.0 % | 18 | 100.0 % | -10.77% |
Sales per region
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 21 | 100.0 % | 18 | 100.0 % | -10.77% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
George Sekulich
PSD | President | 59 | 01/19/01 |
Willis Lee
CHM | Chairman | 64 | 17/19/17 |
Yasushi Nagasaki
DFI | Director of Finance/CFO | 57 | 01/11/01 |
Mark Diamond
CIO | Chief Investment Officer | - | - |
Charles Stark
CTO | Chief Tech/Sci/R&D Officer | 68 | 01/13/01 |
Lan T. Tran
ADM | Chief Administrative Officer | 48 | 17/19/17 |
Dale E. Short
SEC | Corporate Secretary | - | 01/18/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Wei Peu Zen
BRD | Director/Board Member | 71 | 17/19/17 |
Willis Lee
CHM | Chairman | 64 | 17/19/17 |
Ian Zwicker
BRD | Director/Board Member | 77 | 17/19/17 |
George Sekulich
PSD | President | 59 | 01/19/01 |
Seah LIm
BRD | Director/Board Member | 66 | 04/22/04 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 53,637,554 | 25,870,168 ( 48.23 %) | 0 | 48.23 % |
Company contact information
Emmaus Life Sciences, Inc.
21250 Hawthorne Boulevard Suite 800
90503, Torrance
+
http://www.emmausmedical.com![address MYnd Analytics Inc](https://cdn.zonebourse.com/static/address/36911398.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+38.36% | 52.73B | |
+38.62% | 39B | |
-8.63% | 38.52B | |
+25.46% | 30.38B | |
-11.17% | 26.39B | |
+11.44% | 26.08B | |
+45.09% | 14.15B | |
+32.93% | 12.6B | |
-5.30% | 11.51B |